75 related articles for article (PubMed ID: 38702077)
1. Efficacy and Safety of Naftifine Hydrochloride 2% Gel in Interdigital Tinea Pedis: A Phase III Randomised, Double-Blind, Parallel-Group, Active-Controlled Study in Indian Adult Patients.
Sinha SD; Rajamma A; Bandi MR; Sriramadasu SC; Sahu S; Kothiwala RK; Halder S; Sankerneni A; Panapakam M; Vemireddy VNR; Vattipalli R; Devireddy SR
Clin Drug Investig; 2023 Jul; 43(7):565-574. PubMed ID: 37462803
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
Rao MKP; Siddananjappa L; Sidana N; Deshmukh A; Diwari B; Podder I; Kumar S; Mittal R; Daultani P; Jaiswal A; Chinda M
Cureus; 2024 May; 16(5):e60162. PubMed ID: 38868264
[TBL] [Abstract][Full Text] [Related]
3. Oral antifungal medication for toenail onychomycosis.
Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Feng X; Xiong X; Ran Y
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
[TBL] [Abstract][Full Text] [Related]
5. How effective is topical miconazole or amorolfine for mild to moderately severe onychomycosis in primary care: the Onycho Trial - a randomised double-blind placebo-controlled trial.
Watjer RM; Bonten TN; Sayed K; Quint KD; van der Beek MT; Mertens BJA; Numans ME; Eekhof JAH
BMJ Open; 2024 May; 14(5):e081914. PubMed ID: 38702077
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Auvinen T; Tiihonen R; Soini M; Wangel M; Sipponen A; Jokinen JJ
Br J Dermatol; 2015 Oct; 173(4):940-8. PubMed ID: 26036329
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
8. A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
Blume-Peytavi U; Tosti A; Falqués M; Tamarit ML; Carreño C; Galván J; Tebbs V
Mycoses; 2022 Apr; 65(4):392-401. PubMed ID: 34752667
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis: results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs.
Elewski BE; Ghannoum MA; Mayser P; Gupta AK; Korting HC; Shouey RJ; Baker DR; Rich PA; Ling M; Hugot S; Damaj B; Nyirady J; Thangavelu K; Notter M; Parneix-Spake A; Sigurgeirsson B
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):287-94. PubMed ID: 22181693
[TBL] [Abstract][Full Text] [Related]
10. HSP90 Modulates T2R Bitter Taste Receptor Nitric Oxide Production and Innate Immune Responses in Human Airway Epithelial Cells and Macrophages.
Carey RM; Hariri BM; Adappa ND; Palmer JN; Lee RJ
Cells; 2022 Apr; 11(9):. PubMed ID: 35563784
[TBL] [Abstract][Full Text] [Related]
11. Onychomycosis in Older Adults: Prevalence, Diagnosis, and Management.
Gupta AK; Venkataraman M; Talukder M
Drugs Aging; 2022 Mar; 39(3):191-198. PubMed ID: 35102533
[TBL] [Abstract][Full Text] [Related]
12. Topical and device-based treatments for fungal infections of the toenails.
Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Onychomycosis on Quality of Life: A Systematic Review of the Available Literature.
Gupta AK; Mays RR
Skin Appendage Disord; 2018 Oct; 4(4):208-216. PubMed ID: 30410887
[TBL] [Abstract][Full Text] [Related]
14. Onychomycosis: Clinical overview and diagnosis.
Lipner SR; Scher RK
J Am Acad Dermatol; 2019 Apr; 80(4):835-851. PubMed ID: 29959961
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
